Left ventricular geometry in patients with obstructive sleep apnea coexisting with treated systemic hypertension

Respiration

Volumn 74, Issue 2, 2007, Pages 176-183

  Myslinski, Wojciech ^a   Duchna, Hans Werner ^b   Rasche, Kurt ^b   Dichmann, Manuel ^b   Mosiewicz, Jerzy ^a   Schultze Werninghaus, Gerhard ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Antihypertensive agents; Echocardiography; Left ventricular hypertrophy; Obstructive sleep apnea; Systemic hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART PROTECTION; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 33847381084     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091187     Document Type: Article

References (35)

1. Kraiczi H, Peker Y, Caidahl K, Samuelsson A, Hedner J: Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens 2001;19:2071-2078.
2. National High Blood Pressure Education Program: The Seventh Report of the Joint Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, NIH/National Heart, Lung and Blood Institute, 2003.
3. Fletcher EC: The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995;98:118-128.
4. Hedner J, Ejnell H, Caidahl K: Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990;8:941-946.
5. Alchanatis M, Paradellis G, Pini H, Tourkohoriti G, Jordanoglou J: Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 2000;67:367-371.
6. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M: Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995;107:1538-1544.
7. Lentner C: Geigy Scientific Tables: Heart and Circulation, vol 5. Basel, Ciba-Geigy, 1990, p 38.
8. Devereux R: Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparisons to other methods. Hypertension 1987;9:19-26.
9. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al: The heart in hypertension. N Engl J Med 1992;327:998-1008.
10. Rasche K, Sanner B, Schäfer T, Schläfke ME, Sturm A, Zidek W, Schultze-Werninghaus G: Schlafbezogene Atmungsstörungen in Klinik und Praxis. Berlin, Blackwell, 1999.
11. Report of an American Academy of Sleep Medicine Task Force: Sleep-related breathing disorders in adults: recommendations for syndrome defi nition and measurement techniques in clinical research. Sleep 1999;22:667-681.
12. Kahan T: The importance of left ventricular hypertrophy in human hypertension. J Hypertens 1998;16(suppl 7):S23-S29.
13. Cuspidi C, Michev I, Meani S, Salerno M, Valerio C, Fusi V, et al: Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure control. J Hypertens 2003;21:1575-1581.
14. Fagard RH, Staessen JA, Thijs L: Relationships between changes in left ventricular mass and in clinic ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997;15:1493-1502.
15. Cloward TW, Walker JM, Farney RJ, Anderson JL: Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003;124:594-601.
16. Palatini P, Frigo G, Vriz O, Bertolo O, Dal Follo M, Daniele L, et al, HARVEST Study Group: Early signs of cardiac involvement in hypertension. Am Heart J 2001;142:1016-1023.
17. Berman EJ, Di Benedetto RJ, Causey DE, Mims T, Conneff M, Goodman LS, et al: Right ventricular hypertrophy detected by echocardiography in patients with newly-diagnosed obstructive sleep apnoea. Chest 1991;100:347-350.
18. Dursunoǧlu N, Dursunoǧlu D, Kilic M: Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index. Respiration 2005;72:278-284.
19. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-1241.
20. Hatipoǧlu U, Rubinstein I: Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003;70:665-671.
21. Cherniack NS: New mechanisms for the cardiovascular effects of sleep apnea. Am J Med 2000;109:592-594.
22. Narkiewicz K, Somers VK: Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003;177:385-390.
23. Dart RA, Gregoire JR, Gutterman DD, Woolf SH: The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 2003;123:244-260.
24. Schrier RW, Abraham WT: Mechanisms of disease: hormones and hemodynamics. N Engl J Med 1999;341:577-585.
25. Moller DS, Lind P, Strunge B, Pedersen EB: Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003;16:274-280.
26. Saarelainen S, Hasan J, Siitonen S, Seppala E: Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea. J Sleep Res 1996;5:181-185.
27. McGuire M, Bradford A: Chronic intermittent hypoxia increases haematocrit and causes right ventricular hypertrophy in the rats. Respir Physiol 1999;9:53-58.
28. Krieger J, Laks L, Wilcox I, Grunstein RR, Costas LJ, McDougall, et al: Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and after treatment with nasal continuous positive airway pressure. Clin Sci 1989;77:401-411.
29. Schäfer H, Ehlenz K, Ewig S, Hasper E, Koehler U, Latzelsberger J, et al: Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome. J Sleep Res 1999;8:205-210.
30. Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoffmann R, Peter JH: Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Clin Pharmacol 1991;78:124-130.
31. Kraiczi H, Hedner J, Peker Y, Grote L: Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-1428.
32. Grote L, Hedner J, Grunstein R, Kraiczi H: Therapy with nCPAP: incomplete elimination of sleep-related breathing disorder. Eur Respir J 2000;16:921-927.
33. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al: Sleep-disorders breathing and cardiovascular disease. Am J Respir Crit Care Med 2001;163:19-25.
34. Magni P, Motta M: Aldosterone receptor antagonists: biology and novel therapeutical applications. J Endocrinol Invest 2003;26:788-798.
35. McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, et al: Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. Eur Heart J 2003;24:1727-1734.